To investigate the healthy participant bias in a population-based case-control study on breast cancer and assess its impact on mortality outcomes, particularly focusing on the differences in mortality rates between cases and controls.
Key Findings:
Participation rates were 43.4% for controls and 64.1% for cases, indicating a significant difference in engagement.
Overall mortality for controls was significantly lower than the reference population (SMR 0.66), suggesting a healthy participant effect.
SMRs for causes of death other than breast cancer were similar in cases (0.70) and controls (0.64), indicating consistent health status across groups.
Higher education correlated with lower SMRs in both groups, highlighting the role of socioeconomic factors in health outcomes.
Interpretation:
The healthy participant bias is unlikely to significantly distort results in this study, as similar effects were observed in both cases and controls, suggesting that findings may be reliable for broader epidemiological implications.
Limitations:
The true risk factor distribution in the underlying population is unknown, limiting adjustment for bias and potentially affecting the validity of findings.
Low response rates among controls raise questions about the validity of odds ratio estimates, as they may not represent the general population accurately.
Conclusion:
The study suggests that while healthy participant bias exists, it may not significantly affect the validity of findings in this specific case-control study on breast cancer.
